Illidge, TM; Phillips, EH; Counsell, N; Pettengell, R; Johnson, PWM; Culligan, DJ; Popova, B; Clifton-Hadley, L; McMillan, A; Hoskin, P; et al. Illidge, TM; Phillips, EH; Counsell, N; Pettengell, R; Johnson, PWM; Culligan, DJ; Popova, B; Clifton-Hadley, L; McMillan, A; Hoskin, P; Barrington, SF; Radford, J (2020) Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma. Blood Adv, 4 (1). pp. 203-206. ISSN 2473-9537 https://doi.org/10.1182/bloodadvances.2019001023
SGUL Authors: Pettengell, Ruth

Preview

PDF Published Version Available under License ["licenses_description_publisher" not defined]. Download (721kB) | Preview

Item Type:	Article
Additional Information:	© 2020 by The American Society of Hematology
SGUL Research Institute / Research Centre:	Academic Structure > Institute of Medical & Biomedical Education (IMBE) Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title:	Blood Adv
ISSN:	2473-9537
Language:	eng
Dates:	Date Event 14 January 2020 Published 4 December 2019 Accepted
Publisher License:	Publisher's own licence
Projects:	Project ID Funder Funder ID UNSPECIFIED Bloodwise UNSPECIFIED UNSPECIFIED Lymphoma Research Trust UNSPECIFIED UNSPECIFIED Teenage Cancer Trust UNSPECIFIED UNSPECIFIED Department of Health http://dx.doi.org/10.13039/501100000276 UNSPECIFIED Cancer Research UK http://dx.doi.org/10.13039/501100000289 RP-2-16-07-001 National Institute for Health Research http://dx.doi.org/10.13039/501100000272 UNSPECIFIED Engineering and Physical Sciences Research Council http://dx.doi.org/10.13039/501100000266 UNSPECIFIED Medical Research Council http://dx.doi.org/10.13039/501100000265
PubMed ID:	31935289
Web of Science ID:	WOS:000507590000024
	Go to PubMed abstract
URI:	https://openaccess.sgul.ac.uk/id/eprint/111664
Publisher's version:	https://doi.org/10.1182/bloodadvances.2019001023

Actions (login required)

Edit Item